Hepion Pharmaceuticals, Inc.
HEPA
$0.06
$0.00-1.54%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -42.59% | -26.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -60.69% | 4.86% | |||
| Operating Income | 60.69% | -4.86% | |||
| Income Before Tax | 54.68% | 82.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.68% | 82.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.68% | 82.92% | |||
| EBIT | 60.69% | -4.86% | |||
| EBITDA | 61.04% | -4.89% | |||
| EPS Basic | 55.76% | 95.73% | |||
| Normalized Basic EPS | 62.06% | 74.34% | |||
| EPS Diluted | 55.76% | 95.73% | |||
| Normalized Diluted EPS | 62.06% | 74.34% | |||
| Average Basic Shares Outstanding | 2.58% | 299.34% | |||
| Average Diluted Shares Outstanding | 2.58% | 299.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||